These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38539254)

  • 1. Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study.
    Krijtenburg P; de Boer A; Bash LD; Scheffer GJ; Keijzer C; Warlé MC
    Perioper Med (Lond); 2024 Mar; 13(1):22. PubMed ID: 38539254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study).
    Greco M; Caruso PF; Angelotti G; Aceto R; Coppalini G; Martinetti N; Albini M; Bash LD; Carvello M; Piccioni F; Monzani R; Montorsi M; Cecconi M
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of neuromuscular blockade reversal in the evaluation of acute neurosurgical patients: A retrospective case-series.
    Christodoulides A; Palma S; Zaazoue MA; Huh A; Tobin MK; Dine SA; Huh M; Bradbury JL
    J Clin Neurosci; 2022 Oct; 104():82-87. PubMed ID: 35981464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of postoperative residual neuromuscular blockade - A multicenter, observational study in Portugal (INSPIRE 2).
    Esteves S; Correia de Barros F; Nunes CS; Puga A; Gomes B; Abelha F; Machado H; Ferreira M; Fernandes N; Vítor P; Pereira S; Lapa TA; Pinho-Oliveira V
    Porto Biomed J; 2023; 8(4):e225. PubMed ID: 37547706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
    Bash LD; Black W; Turzhitsky V; Urman RD
    Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.
    Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Garzon-Siatoya WT; Renew JR; Hernandez-Torres V; Volcheck GW
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):466-473.e5. PubMed ID: 36108924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.
    Domenech G; Kampel MA; García Guzzo ME; Novas DS; Terrasa SA; Fornari GG
    BMC Anesthesiol; 2019 Aug; 19(1):143. PubMed ID: 31390986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey.
    Kim JS; Han JW; Lee JH; Choi JM; Kim HJ; Sung TY; Kim YB; Shin YS; Yang HS
    Anesth Pain Med (Seoul); 2019 Oct; 14(4):441-448. PubMed ID: 33329775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
    Palsen S; Wu A; Beutler SS; Gimlich R; Yang HK; Urman RD
    J Clin Monit Comput; 2019 Jun; 33(3):455-462. PubMed ID: 30094585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
    Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
    Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of residual neuromuscular blockade: A systematic review of observational studies.
    Raval AD; Anupindi VR; Ferrufino CP; Arper DL; Bash LD; Brull SJ
    J Clin Anesth; 2020 Nov; 66():109962. PubMed ID: 32585565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quantitative versus qualitative neuromuscular blockade monitoring on rocuronium consumption in patients undergoing abdominal and gynecological surgery: a retrospective cohort study.
    Blum LV; Steeger E; Iken S; Lotz G; Zinn S; Piekarski F; Zacharowski K; Raimann FJ
    J Clin Monit Comput; 2023 Apr; 37(2):509-516. PubMed ID: 35986228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
    Jiang Y; Bash LD; Saager L
    Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis.
    Vieira Carlos R; Luis Abramides Torres M; de Boer HD
    Paediatr Anaesth; 2018 Apr; 28(4):342-346. PubMed ID: 29399936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.